AAAAAA
Results: 26-50/73
Authors:
GUIJARRO C
KEANE WF
Citation: C. Guijarro et Wf. Keane, EFFECTS OF LIPIDS ON THE PATHOGENESIS OF PROGRESSIVE RENAL-FAILURE - ROLE OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS IN THE PREVENTION OF GLOMERULOSCLEROSIS, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 147-152
Authors:
HIRATADULAS CAI
RITHNAJARIAN SJ
MCINTYRE MC
ROSS C
DAHL DC
KEANE WF
KASISKE BL
Citation: Cai. Hiratadulas et al., RISK-FACTORS FOR NEPHROPATHY AND CARDIOVASCULAR-DISEASE IN DIABETIC NORTHERN MINNESOTA AMERICAN-INDIANS, Clinical nephrology, 46(2), 1996, pp. 92-98
Authors:
MASSY ZA
KEANE WF
Citation: Za. Massy et Wf. Keane, PATHOGENESIS OF ATHEROSCLEROSIS, Seminars in nephrology, 16(1), 1996, pp. 12-20
Authors:
MASSY ZA
KEANE WF
KASISKE BL
Citation: Za. Massy et al., INHIBITION OF THE MEVALONATE PATHWAY - BENEFITS BEYOND CHOLESTEROL REDUCTION, Lancet, 347(8994), 1996, pp. 102-103
Authors:
KEANE WF
Citation: Wf. Keane, LIPIDS AND PROGRESSIVE RENAL-FAILURE, Wiener Klinische Wochenschrift, 108(14), 1996, pp. 420-424
Authors:
CRARY GS
SWAN SK
ODONNELL MP
KASISKE BL
KATZ SA
KEANE WF
Citation: Gs. Crary et al., THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN REDUCES BLOOD-PRESSURE BUT NOT RENAL INJURY IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 6(4), 1995, pp. 1295-1299
Authors:
HIRATADULAS CAI
DAHL DC
MODI K
MA JZ
COLLINS AJ
KEANE WF
Citation: Cai. Hiratadulas et al., SURVIVAL OF TYPE-II DIABETIC (DM-II) NATIVE-AMERICAN INDIANS (NAI) ONHEMODIALYSIS (HD) IS BETTER THAN CAUCASIANS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 534-534
Authors:
MASSY ZA
KASISKE BL
GUIJARRO C
KIM Y
KEANE WF
ODONNELL MP
Citation: Za. Massy et al., BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF, Journal of the American Society of Nephrology, 6(3), 1995, pp. 800-800
Authors:
GUIJARRO C
KASISKE BL
KIM YK
ODONNELL MP
LEE HS
KEANE WF
Citation: C. Guijarro et al., EARLY GLOMERULAR CHANGES IN RATS WITH DIETARY-INDUCED HYPERCHOLESTEROLEMIA, American journal of kidney diseases, 26(1), 1995, pp. 152-161
Authors:
FOOTE EF
LOOK ZM
GILES P
KEANE WF
HALSTENSON CE
Citation: Ef. Foote et al., THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS, American journal of kidney diseases, 25(3), 1995, pp. 420-425
Authors:
BENNETT PH
HAFFNER S
KASISKE BL
KEANE WF
MOGENSEN CE
PARVING HH
STEFFES MW
STRIKER GE
Citation: Ph. Bennett et al., SCREENING AND MANAGEMENT OF MICROALBUMINURIA IN PATIENTS WITH DIABETES-MELLITUS - RECOMMENDATIONS TO THE SCIENTIFIC-ADVISORY-BOARD OF THE NATIONAL-KIDNEY-FOUNDATION FROM AN AD-HOC-COMMITTEE OF THE COUNCIL-ON DIABETES-MELLITUS OF THE NATIONAL-KIDNEY-FOUNDATION, American journal of kidney diseases, 25(1), 1995, pp. 107-112
Authors:
SICA DA
LO MW
SHAW WC
KEANE WF
GEHR TWB
HALSTENSON CE
LIPSCHUTZ K
FURTEK CI
RITTER MA
SHAHINFAR S
Citation: Da. Sica et al., THE PHARMACOKINETICS OF LOSARTAN IN RENAL-INSUFFICIENCY, Journal of hypertension, 13, 1995, pp. 49-52
Authors:
MOGENSEN CE
KEANE WF
BENNETT PH
JERUMS G
PARVING HH
PASSA P
STEFFES MW
STRIKER GE
VIBERTI GC
Citation: Ce. Mogensen et al., PREVENTION OF DIABETIC RENAL-DISEASE WITH SPECIAL REFERENCE TO MICROALBUMINURIA, Lancet, 346(8982), 1995, pp. 1080-1084
Authors:
WONG MO
ELDON MA
KEANE WF
TURCK D
BOCKBRADER HN
UNDERWOOD BA
SEDMAN AJ
HALSTENSON CE
Citation: Mo. Wong et al., DISPOSITION OF GABAPENTIN IN ANURIC SUBJECTS ON HEMODIALYSIS, Journal of clinical pharmacology, 35(6), 1995, pp. 622-626
Authors:
FOOTE EF
LEE DR
KARIM A
KEANE WF
HALSTENSON CE
Citation: Ef. Foote et al., DISPOSITION OF MISOPROSTOL AND ITS ACTIVE METABOLITE IN PATIENTS WITHNORMAL AND IMPAIRED RENAL-FUNCTION, Journal of clinical pharmacology, 35(4), 1995, pp. 384-389
Authors:
KASISKE B
KEANE WF
VANRENTERGHEM Y
Citation: B. Kasiske et al., CHRONIC RENAL-ALLOGRAFT FAILURE - CUENCA, SPAIN, JULY 7-9 1995 - INTRODUCTION, Kidney international, 48, 1995, pp. 1-1
Authors:
ODONNELL MP
KASISKE BL
MASSY ZA
GUIJARRO C
SWAN SK
KEANE WF
Citation: Mp. Odonnell et al., ISOPRENOIDS AND RAS - POTENTIAL ROLE IN CHRONIC REJECTION, Kidney international, 48, 1995, pp. 29-33
Authors:
KIM SY
GUIJARRO C
ODONNELL MP
KASISKE BL
KIM YK
KEANE WF
Citation: Sy. Kim et al., HUMAN MESANGIAL CELL PRODUCTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1- MODULATION BY LOVASTATIN, Kidney international, 48(2), 1995, pp. 363-371
Authors:
SWAN SK
CRARY GS
GUIJARRO C
ODONNELL MP
KEANE WF
KASISKE BL
Citation: Sk. Swan et al., IMMUNOSUPPRESSIVE EFFECTS OF LEFLUNOMIDE IN EXPERIMENTAL CHRONIC VASCULAR REJECTION, Transplantation, 60(8), 1995, pp. 887-890
Authors:
GUIJARRO C
KEANE WF
Citation: C. Guijarro et Wf. Keane, HYPERLIPIDEMIA AND NEPHROPATHY - CAUSE OR CONSEQUENCE, Medicina Clinica, 105(13), 1995, pp. 496-497
Authors:
STPETER JV
SWAN SK
HALSTENSON CE
KASISKE BL
COLLINS AJ
ELLEFSON J
KEANE WF
Citation: Jv. Stpeter et al., ACCURATE AND EFFICIENT DETERMINATION OF RESIDUAL RENAL-FUNCTION (RRF)WITH IOHEXOL (IO) CLEARANCE IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 529-529
Authors:
GUIJARRO C
KIM Y
SHOONOVER CM
ODONNELL MP
KASISKE BL
KEANE WF
Citation: C. Guijarro et al., LOVASTATIN (LOV) INHIBITS LIPOPOLYSACCHARIDE (LPS) STIMULATED MESANGIAL CELL (MC) NF-KAPPA-B ACTIVATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 750-750
Authors:
PARK YS
ODONNELL MP
KIM Y
KASISKE BL
GUIJARRO C
KEANE WF
Citation: Ys. Park et al., DIFFERENTIAL-EFFECTS OF LOVASTATIN ON GLOMERULAR AND INTERSTITIAL MACROPHAGE (M-PHI) INFILTRATION IN NEPHROTIC RATS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 762-762
Authors:
ODONNELL MP
CHAO C
HU S
KEANE WF
Citation: Mp. Odonnell et al., THE HIV-1 ENVELOPE PROTEIN GP120 STIMULATES MESANGIAL CELL PRODUCTIONOF TNF-A, Journal of the American Society of Nephrology, 5(3), 1994, pp. 790-790
Authors:
CRARY GS
SWAN SK
ODONNELL MP
KASISKE BL
KATZ SA
KEANE WF
Citation: Gs. Crary et al., ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST LOWERS BLOOD-PRESSURE (BP) BUT DOES NOT REDUCE RENAL INJURY IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 941-941